Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 67–67 | Cite as

Atezolizumab

Polymyalgia rheumatica: case report
Case report

Reference

  1. Chan KK, et al. Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor. Annals of the Rheumatic Diseases 78: No. 7, Jul 2019. Available from: URL: http://doi.org/10.1136/annrheumdis-2018-213672 -USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations